Pathophysiology and clinical assessment of parkinsonian symptoms and signs

Handbook of Parkinson's Disease, Third Edition

Volumn , Issue , 2003, Pages 71-107

  Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973406684     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (108)

1. Parkinson J. An Essay on the Shaking Palsy. London: Sherwood, Neely, and Jones, 1817.
2. Ford B, Louis ED, Greene P, Fahn S. Oral and genital pain syndromes in Parkinson’s disease. Mov Disord 1996; 11:421-426.
3. Reichert WH, Doolittle J, McDowell FM. Vestibular dysfunction in Parkinson’s disease. Neurology 1982; 32:1 133-1138.
4. Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia in Parkinson’s disease. A community-based, prospective study. Neurology 2001; 56:730-736.
5. Dubois B, Pillon B. Cognitive and behavioral aspects of basal ganglia disorders. In: Jankovic J, Tolosa E, eds. Parkinson’s Disease and Movement Disorders. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2002.
6. Giladi N, Burke RE, Kostic V, et al. Hemiparkinsonism-hetniatrophy syndrome: clinical and neuroradiologic features. Neurology 1990; 40: 1731-1734.
7. Bulpitt CJ, Shaw K, Clifton P, Stenn G, Davies JB, Reid IL. The symptoms of patients treated for Parkinson’s disease. Clin Neuropharmacol 1985; 8:175-183.
8. Gonera EG, van’t Hof M, Berger HJC, et al. Symptoms and duration of the prodromal phase in Parkinson’s disease. Mov Disord 1997; 12:871-876.
9. Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease. Arch Neurol 2000; 57:369-372.
10. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125:861-870.
11. Jankovic J. Clinical aspects of Parkinson’s disease. In: Marsden CD, Fahn, S, eds. New Trends in the Treatment of Parkinson’s Disease. Carnforth, England: Parthenon Publishing, 1991:53-76.
12. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. Neurology 1990; 40:1529-1534.
13. Jenkyn LR, Reeves AG, Warren T, et al. Neurologic signs in senescence. Arch Neurol 1984; 42:1154-1157.
14. Wagner HN. Probing the chemistry of the mind. N Engl J Med 1985; 312:4446.
15. Newman RP, LeWitt PA, Jaffe M, Calne DB, Larsen TA. Motor function in the normal aging population: treatment with levodopa. Neurology 1985; 35:571-573.
16. Marsden CD. The pathophysiology of movement disorders. Neurol Clin North Am 1984; 2:435-459.
17. Jankovic J, Ben-Arie L, Schwartz K, Chen K, Kahn K, Lai EC, Krauss JK, Grossman R. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord 1999; 14:57-62.
18. Bagheri H, Damase-Michel C, Lapeyre-Mestre M, et al. A study of salivary secretion in Parkinson’s disease. Clin Neuropharm 1999; 22213-22215.
19. Teulings H-L, Contreras-Vidal JL, Stelmach GE, Adler CH. Adaptation of handwriting size under distorted visual feedback in patients with Parkinson’s disease and elderly and young controls. J Neurol Neurosurg Psychiatry 2002; 72:315-324.
20. Rafal RD, Posner MI, Walker JA, Friedrich FJ. Cognition and the basal ganglia: separating mental and motor components of performance in Parkinson’s disease. Brain 1984; 107:1083-1094.
21. Hallett M, Khoshbin S. A physiological mechanism of bradykinesia. Brain1980; 103:301-314.
22. Jankovic J, Frost JD. Quantitative assessment of parkinsonian and essential tremor: clinical application of triaxial accelerometry. Neurolory 1981; 31:1235-1240.
23. Baroni A, Benvenuti F, Fantini L, Pantaleo T, Urbani F. Human ballistic arm abduction movements: effects of L-dopa treatment in Parkinson’s disease. Neurology 1984; 34:868-876.
24. Freed CR, Yamamoto BK. Regional brain dopamine metabolism: a marker for the speed, direction, and posture of moving animals. Science 1985; 229:6265.
25. Ito M. The Cerebellum and Neural Control. New York: Raven Press, 1984.
26. Vingerhoets FJG, Schulzer M, Calne DB, et al. Which clinical sign of Parkinson’s disease best reflects the nigrostriatal lesion? Ann Neurol 1997; 41:58-64.
27. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249:1436-1438.
28. Dostrovsky JO, Hutchinson WD, Lozano AM. The globus pallidus, deep brain stimulation and Parkinson’s disease. Neuroscientist 2002; 8:284-290.
29. Brown P. Muscle sounds in Parkinson’s disease. Lancet 1997; 349:533-535.
30. Farmer S. Neural rhythms in Parkinson’s disease. Brain 2002; 125:1175-1176.
31. Levy R, Ashby P, Hutchison WD, Lang AE, Lozano AM, Dostrovsky JO. Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson’s disease. Brain 2002; 125:1196-1209.
32. Lakke JPWF. Axial apraxia in parkinson’s disease. J Neurol Sci 1985; 69:3746.
33. Marsden CD. The mysterious motor function of the basal ganglia. Neurology1982; 32:514-539.
34. Schultz W. Recent physiological and pathophysiological aspects of parkinsonian movement disorders. Life Sci 1984; 34:2213-2223.
35. Dick JPR, Rothwell JC, Day BL, et al. The Bereitschaftpotential is abnormal in Parkinson’s disease. Brain 1989; 112:233-244.
36. Tatton WG, Eastovan MJ, Bedingham W, Verrier MC, Bruce IC. Defective utilization of sensory input as the basis for bradykinesia, rigidity and decreased movement repertoire in parkinson’s disease: a hypothesis. Can J Neurol Sci 1984; 11:136-147.
37. Stern Y, Mayeux R, Rosen J, Illson J. Perceptual motor dysfunction in Parkinson’s disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatry 1983; 46:145-151.
38. Evarts EV, Teravainen M, Calne DB. Reaction time in Parkinson’s disease. Brain 1981; 104:167-1861.
39. Yokochi F, Nakamura R, Narabayashi H. Reaction time of patients with Parkinson’s disease with reference to asymmetry of neurological signs. J Neurol Neurosurg Psychiatry 1985; 48:702-705.
40. Pirozzolo FJ, Jankovic J, Mahurin RK. Differentiation of choice reaction time performance in Parkinson’s disease on the basis of motor symptoms. Neurology 1985; 35(suppl 1):222.
41. Dick PJR, Cantello R, Buruma O, et al. The Bereitschaftspotential, L-dopa and Parkinson’s disease. Electroencephalogr Clin Neurophysiol 1987; 66:263-274.
42. Ward CD, Sanes JN, Dambrosia JM, Calne DB. Methods for evaluating treatment in Parkinson’s disease. In: Fahn S, CaIne DB, Shoulson I, eds. Experimental Therapeutics of Movement Disorders. New York: Raven Press, 1983:1-7.
43. Martin WE, Loewenson RB, Resch JA, Baker AB. Parkinson’s disease. Clinical analysis of 100 patients. Neurology 1983; 23:783-790.
44. Jankovic J. Essential tremor: a heterogeneous disorder. Mov Disord 2002 (in press).
45. Jankovic J, Schwartz, KS, Ondo W. Re-emergent tremor of Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999; 67:646-650.
46. Findley LJ, Gresty MA. Tremor and rhythmical involuntary movements in Parkinson’s disease. In: Findley LJ, Capildeo R, eds. Movement Disorders: Tremors. New York: Oxford University Press, 1984:295-304.
47. Llinas R, Jahnsen H. Electrophysiology of mammalian thalamic neurons in vitro. Nature 1982; 297:406-408.
48. Lamarre Y. Animal models of physiological, essential and parkinsonian-like tremors. In: Findley LJ, Capildeo R, eds. Movement Disorders: Tremor. New York: Oxford University Press, 1984:183-194.
49. Lee RG, Stein RB. Resetting of tremor by mechanical perturbations: a comparison of essential tremor and parkinsonian tremor. Ann Neurol 1981; 10:523-531.
50. Kelly PJ, Ahlskog JE, Goerss SJ, et al. Computer-assisted stereotactic ventralis lateralis thalamatomy with microelectrode recording control in patients with Parkinson’s disease. Mayo Clin Proc 1987; 62:655-664.
51. Findley LJ, Gresty MA, Halmagyi GM. Tremor, the cogwheel phenomenon and clonus in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1981; 44:534-546.
52. Bernheimer H, Birkmayer W, Horrnykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington: clinical morphological and neurochemical correlations. J Neurol Sci 1973; 20:415-455.
53. Pechadre JC, Larochelle I, Poirier LJ. Parkinsonian akinesia, rigidity and tremor in the monkey. Histopathological and neuropharmacological study. J Neurol Sci 1976; 28:147-157.
54. Ballard PA, Tetrud JW, Laneston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 1985; 35:949-956.
55. Snyder SH, D’Amato RI. MPT: A neurotoxin relevant to the pathophysiology of Parkinson’s disease. Neurology 1986; 36:250-258.
56. Holmes G. Clinical symptoms of cerebellar disease and their interpretation. Lancet 1922; 1:1231-1237.
57. Snider SR, Fahn S, Isgreen WP, et al. Primary sensory symptoms in parkinsonism. Neurology 1979; 26:423-429.
58. Koller WC. Sensory symptoms in Parkinson’s disease. Neurology 1984; 34:957-959.
59. Matsumoto K, Rossomann F, Lin TH, Cooper IS. Studies on induced exacerbation of parkinsonian rigidity. The effect of contralateral voluntary activity. J Neurol Neurosurg Psychiatry 1963; 26:27-32.
60. Riley D, Lang AE, Blair RDG, et al. Frozen shoulder and other disturbances in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1989; 52:63-66.
61. Jankovic J, Tintner R. Dystonia and parkinsonism. Parkinson’s Dis Relat Disord 2001; 8:109-121.
62. Askmark H, Edebol Eeg-Olofsson K, Johnsson A, et al. Parkinsonism and neck extensor myopathy. A new syndrome or coincidental findings? Arch Neurol 2001; 58:232-237.
63. Djaldetti R, Mosberg-Galili R, Sroka H, et al. Camptocormia (bent spine) in patients with Parkinson’s disease—characterization and possible pathogenesis of an unusual phenomenon. Mov Disord 1999; 14:443-447.
64. Jankovic J, Fahn S. Dystonic disorders. In: Jankovic J, Tolosa E, eds. Parkinson’s Disease and Movement Disorders. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2002.
65. Duvoisin RC, Marsden CD. Note on the scoliosis of parkinsonism. J Neurol Neurosurg Psychiatry 1975; 38:787-793.
66. Grimes JD, Hassan MN, Trent G, Halle D, Armstrong GW. Clinical and radiographic features of scoliosis in Parkinson’s disease. Adv Neurol 1987; 45:353-355.
67. Burke D. Pathophysiologic aspects of rigidity and dystonia. In: Benecke R, Conrad B, Marsden CD, eds. Motor Disturbances I. London: Academic Press, 1987:87-100.
68. Mortimer JA, Webster D. Evidence for a quantitative association between EMG stretch responses and parkinsonian rigidity. Brain Res 1979; 162:169-173.
69. Berardelli A, Sabra AF, Hallett M. Physiologic mechanisms of rigidity in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1983; 46:45-53.
70. Lee RG, Tatton WG. Motor responses to sudden limb displacements in primates with specific CNS lesions and in human patients with motor system disorders. Can J Neurol Sci 1975; 2:285-293.
71. Rothwell JL, Obeso JA, Traub MM, et al. The behavior of the long-latency stretch reflex n patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1983; 76:35-44.
72. Meyer M, Adorjani C. Quantification of the effects of muscle relaxant drugs in man by tonic stretch reflex. In: Desmedt JE, ed. Motor Control Mechanisms in Health and Disease. New York: Raven Press, 1983:997-1012.
73. Marsden CD, Schachter M. Assessment of extrapyramidal disorders. Br J Clin Pharmacol 1981; 11:129-151.
74. Terdvainen H, Caine DB. Quantitative assessment of parkinsonian deficits. In: Rinne UK, Klingler M. Stamm G, eds. Parkinson’s Disease. Current Progress, Problems and Management. Amsterdam: Elsevier/North-Holland, 1980:145-164.
75. Purdon-Martin J. The Basal Ganglia and Posture. Philadelphia: JB Lippincott, 1967.
76. Traub MM, Rothwell JC, Marsden CD. Anticipatory postural reflexes in Parkinson’s disease and other akinetic-rigid syndromes and in cellular ataxia. Brain 1980; 103:393-412.
77. Aita JF. Why patients with Parkinson’s disease fall. JAMA 1982; 247:515-516.
78. Koller WC, Glatt S, Vetere-Overfield B, Hassanein R. Falls in Parkinson’s disease. Clin Neuropharmacol 1989; 12:98-105.
79. Weiner WJ, Nora LM, Glantz RH. Elderly inpatients: postural reflex impairment. Neurology 1984; 34:945-947.
80. Jankovic J, Nutt JG, Sudarsky L. Classification, diagnosis and etiology of gait disorders. In: Ruzicka E, Hallett M, Jankovic J, eds. Gait Disorders. Philadelphia: Lippincott Williams &Wilkins, 2001:119-134.
81. Fisher CM. Hydrocephalus as a cause of disturbance of gait in the elderly. Neurology 1982; 32:1358-1363.
82. Knutsson E, Lying-Tunell M. Gait apraxia in manual-pressure hydrocephalus: problems of movement and muscle activation. Neurology 1985; 35:155-160.
83. Sudarsky L, Ronthal M. Gait disorders among elderly patients. A survey study of 50 patients. Arch Neurol 1983; 40:740-743.
84. Koller WC, Wilson RS, Glatt SL, Huckman MS, Fox JR. Senile gait: Correlation with computed tomographic scans. Ann Neurol 1983; 13:343-344.
85. FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord 1989; 4(3):249-260.
86. Jankovic J, Friedman D, Pirozzolo FJ, McCrary JA. Progressive supranuclear palsy: Clinical, neurobehavioral, and neuro-ophthalmic findings. Adv Neurol1990; 53:293-304.
87. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999; 56:98-102.
88. Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 1997; 12:302-305.
89. Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD. Prospective assessment of the DATATOP cohort. Neurology 2001; 56:1712-1721.
90. Dietz MA, Goetz CG, Stebbins GT. Evaluation of a modified inverted walking stick as a treatment for parkinsonian freezing episodes. Mov Dis1990; 5:243-247.
91. Marchese R, Diverio M, Zucchi F, et al. The role of sensory cues in the rehabilitation of parkinsonian patients: A comparison of two physical therapy protocols. Mov Disord 2001; 15:879-883.
92. Elble RJ, Cousins R, Leffler K, Hughes L. Gait initiation by patients with lower-half parkinsonism. Brain 1996; 119:1705-1716.
93. Critchley M. Speech disorders of parkinsonism: a review. J Neurol Neurosurg Psychiatry 1981; 44:757-758.
94. Hunker CJ, Abbs JH, Barlow SM. The relationship between parkinsonian rigidity and hypokinesia in the orofacial system: a quantitative analysis. Neurology 1982; 32:749-755.
95. Jankovic J. Respiratory dyskinesia in Parkinson’s disease. Neurology 1986; 36:303-304.
96. Rice JE, Antic R, Thompson PD. Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease. Mov Disord 2002; 17:524-527.
97. Jankovic J. Clinical features, differential diagnosis and pathogenesis of blepharospasm and cranial-cervical dystonia. In: Bosniak SL, ed. Blepharospasm. New York: Pergamon Press, 1985:67-82.
98. Leport FE, Duvoisin RC. Apraxia of eyelid opening: an involuntary levator inhibition. Neurology 1985; 35:423-427.
99. Guiloff RJ, George RJ, Marsden CD. Reversible supranuclear ophthalmoplegia associated with parkinsonism. J Neurol Neurosurg Psychiatry 1980; 43:552-554.
100. Zetusky WJ, Jankovic I, Pirozzolo FJ. The heterogeneity of Parkinson’s disease: Clinical and prognostic implications. Neurology 1985; 35:522-526.
101. Jankovic J, Kapadia AS. Functional decline in Parkinson’s disease. Arch Neurol 2001; 58:1611-1615.
102. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17:427-442.
103. Fahn S, Elton RL. Members of the UPDRS Development Committee: Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Caine DB, Lieberman A, eds. Recent Developments in Parkinson’s Disease. Vol. II. Florham Park, NJ: Macmillan Health Care Information, 1987:153-163.
104. Goetz CG, Stebbins GT, Shale HM, et al. Utility of an objective dyskinesia rating scale for Parkinson’s disease: inter- and intrarater reliability assessment. Mov Disord 1994; 9:390-394.
105. Goetz CG, Stebbins GT, Chmura TA, et al. Teaching tape for the motor section of the Unified Parkinson’s Disease Rating Scale. Mov Disord 1995; 10:263-266.
106. Bennett DA, Shannon KM, Beckett LA, et al. Metric properties of nurses’ ratings of parkinsonian signs with a modified Unified Parkinson’s Disease Rating Scale. Neurology 1997; 49:1580-1587.
107. Stebbins GT, Goetz CG, Lang AE, Cubo E. Factor analysis of the motor section of the Unified Parkinson’s Disease Rating Scale during the off-state. Mov Disord 1999; 14:585-589.
108. Marinus J, Ramaker C, Van Hilten JJ, Stiggelbout AM. Health related quality of life in Parkinson’s disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002; 72:241-248.